{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:37:01Z","timestamp":1747172221194,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.wneu.2017.04.083","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T04:46:54Z","timestamp":1492750014000},"page":"952.e5-952.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Intraoperative Eptifibatide Administration During Urgent Arterial Bypass in Neurosurgery"],"prefix":"10.1016","volume":"103","author":[{"given":"Vasilije","family":"Stambolija","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Mrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin","family":"Lozic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josip","family":"Ljevak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-1117","authenticated-orcid":false,"given":"Martina","family":"Miklic Bublic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Scap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.04.083_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2004-833476","article-title":"Platelet receptors for adenine nucleotides and thromboxane A2","volume":"30","author":"Murugappan","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.wneu.2017.04.083_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/2048872612474922","article-title":"Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS","volume":"2","author":"Hess","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.wneu.2017.04.083_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3171\/2010.8.JNS10318","article-title":"Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke","volume":"114","author":"Memon","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.04.083_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1552-6569.2007.00185.x","article-title":"Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke","volume":"18","author":"Qureshi","year":"2008","journal-title":"J\u00a0Neuroimaging"},{"key":"10.1016\/j.wneu.2017.04.083_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000247604","article-title":"Safety of eptifibatide for subcortical stroke progression","volume":"28","author":"Martin-Schild","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2017.04.083_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/neurintsurg-2012-010271","article-title":"Adjunctive use of eptifibatide for complication management during elective neuroendovascular procedures","volume":"5","author":"Dumont","year":"2013","journal-title":"J\u00a0Neurointerv Surg"},{"key":"10.1016\/j.wneu.2017.04.083_bib7","first-page":"1856","article-title":"Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms","volume":"27","author":"Yi","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.wneu.2017.04.083_bib8","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.86.16_supplement.P1.257","article-title":"Novel application of reversible parental anti-platelets in patients with aneurysmal subarachnoid hemorrhage","volume":"86","author":"Mehta","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.04.083_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00234-014-1452-x","article-title":"Administration of eptifibatide during endovascular treatment of ruptured cerebral aneurysms reduces the rate of thromboembolic events","volume":"57","author":"Sedat","year":"2015","journal-title":"Neuroradiology"},{"key":"10.1016\/j.wneu.2017.04.083_bib10","first-page":"8","article-title":"Possible role of eptifibatide drip in patient with aneurysmal subarachnoid hemorrhage in vasospasm prevention","volume":"7","author":"Dababneh","year":"2014","journal-title":"J\u00a0Vasc Interv Neurol"},{"key":"10.1016\/j.wneu.2017.04.083_bib11","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3174\/ajnr.A3447","article-title":"Off-label use of drugs and devices in the neuroendovascular suite","volume":"34","author":"Abdihalim","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.wneu.2017.04.083_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0735-1097(99)00195-3","article-title":"Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention","volume":"34","author":"Rabah","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.wneu.2017.04.083_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.95.1.118","article-title":"Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate","volume":"95","author":"Cosmi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.wneu.2017.04.083_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH03-06-0365","article-title":"Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin","volume":"91","author":"Chan","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.wneu.2017.04.083_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors","volume":"86","author":"Weitz","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.wneu.2017.04.083_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-119-2-199307150-00002","article-title":"Establishing a therapeutic range for heparin therapy","volume":"119","author":"Brill-Edwards","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.wneu.2017.04.083_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/pgmj.2007.059188","article-title":"Heparin induced thrombocytopenia: diagnosis and management update","volume":"83","author":"Ahmed","year":"2007","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.wneu.2017.04.083_bib18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017305788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017305788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T18:08:29Z","timestamp":1719166109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875017305788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":18,"alternative-id":["S1878875017305788"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.04.083","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraoperative Eptifibatide Administration During Urgent Arterial Bypass in Neurosurgery","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.04.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}